Transdermal Estradiol Patches in Prostate Cancer

New England Journal of Medicine · Published 2026-07-29 · DOI 10.1056/nejmc2607173

Authors being retrieved — see the publisher record. https://doi.org/10.1056/nejmc2607173

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Transdermal estradiol for prostate cancer: how do patients compare it to other options for androgen deprivation therapy? · Canadian Journal of Urology · 2026 · Cites or is cited by this article
Health Care–Associated Infections in U.S. Hospitals, 2023 versus 2015 · New England Journal of Medicine · 2026 · Same journal
Phase 3 Trial of Weekly Oral Islatravir–Lenacapavir for HIV-1 Treatment · New England Journal of Medicine · 2026 · Same journal
Mineralocorticoid Receptor Antagonism — FINDing Another Benefit · New England Journal of Medicine · 2026 · Same journal
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer · New England Journal of Medicine · 2026 · Same journal
Time to Stop? Rethinking the Duration of Maintenance Treatment in Multiple Myeloma · New England Journal of Medicine · 2026 · Same journal
Left Ventricular Unloading in High-Risk PCI · New England Journal of Medicine · 2026 · Same journal
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma · New England Journal of Medicine · 2026 · Same journal
Koebner Phenomenon from Wet Cupping · New England Journal of Medicine · 2026 · Same journal
More on Digital Twin–Guided Ablation for Ventricular Tachycardia · New England Journal of Medicine · 2026 · Same journal